Advertisement
NEW YORK, July 10, 2017 /PRNewswire/ -- Read the full report: http://www.reportlinker.com/p04838507/Global-Immunoassay-Systems-Laboratory-Equipment-and-Supplies.htmlThe report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 65 companies including many key and niche players such as - - Abbott Laboratories - Beckman Coulter, Inc. - bioMérieux SA - Bio-Rad Laboratories Inc. Read the full report: http://www.reportlinker.com/p04838507/Global-Immunoassay-Systems-Laboratory-Equipment-and-Supplies.htmlI. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONSStudy Reliability and Reporting LimitationsDisclaimersData Interpretation & Reporting LevelQuantitative Techniques & AnalyticsProduct Definitions and Scope of StudyEnzyme ImmunoassayFluorescence ImmunoassayChemiluminescence ImmunoassayRapid TestsElispotOthersII. EXECUTIVE SUMMARY1. INDUSTRY OVERVIEWImmunoassays - A PrefaceCurrent and Future AnalysisFactors Sustaining Market GrowthFactors Restraining GrowthDeveloping Markets to Drive SalesRadioimmunoassay Systems Lose GroundChemiluminescence Immunoassays Gain DemandExpanding Immunoassay Applications Boost DemandTable 1: Global Laboratory Based Immunoassay Market (2016): Percentage Share Breakdown of Value Sales by Clinical Area (includes corresponding Graph/Chart)2. COMPETITIVE LANDSCAPETable 2: Leading Players in the Global Immunoassay Systems Market (2015) - Percentage Share Breakdown of Sales by Company (includes corresponding Graph/Chart)3. MARKET TRENDS AND ISSUESBespoke Solutions Energize Market GrowthMultiplex Immunoassays Grow in DemandNovel Biomarkers to Boost Market GrowthSERS - An Attractive Readout StrategyAutomated Immunoassay Systems - In Line with Automation TrendTechnological Advances to buoy ELISA's ProspectsAutomation of ELISA - Enabling its SustenanceGrowing Popularity of Multiplexing Deters ELISA MarketCommoditization: A Key Issue Facing ELISA Product ManufacturersConsolidation of Hospitals and Labs Drives DemandPOC and DIA Systems Grow in DemandPrenatal Testing - An Opportunity MarketRise in Infectious Diseases Raises DemandIncreasing Use of Immunoassays in Food Sciences and Quality ControlGrowing Use in Environmental Testing4. MACRO GROWTH DRIVERS AND APPLICATION MARKETSImproving Healthcare Expenditure to Foster GrowthTable 3: Healthcare Spending as % of GDP by Region (2017E) (includes corresponding Graph/Chart)Aging Global Population Buoys Market GrowthTable 4: Global Aging Population in Select Regions/Countries: Population of 60+ Individuals as a Percentage of Total Population for 2015 & 2050 (includes corresponding Graph/Chart)Infectious Disease Diagnosis: The Largest Application AreaIncreasing Incidence of Infectious Diseases - An Opportunity IndicatorTable 5: Reported Cases of Major Infections by Select Geographic Region: 2011Endocrine Testing ProceduresGrowing Diabetes Prevalence Boost Prospects for Immunoassay- based HbA1c TestsTable 6: Worldwide Prevalence of Diabetes Mellitus by Region (2013 & 2035) (includes corresponding Graph/Chart)Table 7: Incidence of Diabetes in Select Countries (2015 & 2040) (includes corresponding Graph/Chart)Blood Processing MarketCancer Testing MarketsDrugs of Abuse Testing MarketTherapeutic Drug MonitoringImmune DiseaseBlood Grouping and Typing5. CONCEPTUAL OVERVIEWImmunoassays - Definition and Description....Down the TimelineImmunoassay AnalyzersImmunoassay ReagentsComponents of ImmunoassaysSignal ResponseLabeled TracerBinderBuffer MatrixIncubation ConditionsSeparation ProcessStandard SpecimensControl SpecimensUnknown SpecimensTypes of Immunoassay AnalyzersAn Insight Into Immunoassay TechnologiesEnzyme Immunoassays (EIA)ELISA - A Renowned and Proven Assay FormatFluorescence Immunoassay - Operating PrincipleChemiluminescence ImmunoassayRadioimmunoassay Analyzers, Gamma CountersRapid TestsELISPOTWestern BlotComparison of Various Immunoassay TechnologiesPurchase Considerations for Analyzers6. PRODUCT LAUNCHES/APPROVALSSekisui Diagnostics Launches new SEKURE® TPLA and RPR Assays for Syphilis TestingSiemens Healthineers Introduces Atellica Solution automated Immunoassay Analyzer SystemAbbott Introduces Alinity™Roche Introduces New Cobas e 801 ModuleSiemens to Release Genetic Assay for Detection of Zika VirusFujirebio Europe Releases the Lumipulse G B•R•A•H•M•S PCT AssayFujirebio Releases "Lumipulse L 2400" CLIA SystemRoche Introduces Elecsys® HTLV-I/II ImmunoassaySiemens Introduces ADVIA Centaur Syphilis AssaySysmex Introduces HISCL-800 Automated Immunoassay SystemSiemens Introduces New Chemistry & Immunoassay SystemsMeso Scale Discovery Launches S-PLEX™ AssaysModern Water Monitoring Introduces New Immunoassay Strip Test and ReadersEnzo Life Sciences Launches Amp'd™ ELISA Signal Amplification KitEMD Millipore Rolls Out New Immunoassay KitsPerkinElmer Launches Novel Research ToolsRoche Releases Elecsys Syphilis Immunoassay7. RECENT INDUSTRY ACTIVITYAbbott Receives CE Mark for Alinity CI-Series Diagnostic SystemsQuidel Receives FDA Clearance for New Solana(R) Molecular AssayQuidel Receives FDA Clearance for Solana(R) Strep Complete AssayFDA Clears ORTHO VISION® Max Analyzer for High-Volume Transfusion Medicine LabsBeckman Coulter Receives FDA Clearance for Access TSH (3rd IS) AssayQuidel Receives FDA Clearance for Solana(R) Influenza A+B AssayOrtho Clinical Diagnostics Receives CE Mark Approval for VITROS® Immunodiagnostic HIV Combo TestSiemens Healthcare Changes Name to Siemens HealthineersDiaSorin to Acquire Focus Diagnostics' Molecular and Immunoassay Product BusinessQuidel Receives CE Mark for Quidel's Sofia® S. pneumoniae Fluorescent ImmunoassayDiaSorin and Beckman Coulter Sign Agreement to Distribute Hepatitis and HIV Tests in ChinabioMérieux Receives FDA 510(k) clearance for VIDAS® 3Quidel Receives FDA Clearance for New Solana™ Molecular System and Solana™ Molecular AssaySiemens Receives FDA Approval for Siemens HIV Combo assayEurofins Acquired ViraCor-IBT LaboratoriesYSL Bio Signs Enters into Agreement with GeneXTechne to Acquire CyVekGyros Enters into Distribution Agreement with Tekon BiotechSingulex Partners with TecanOriGene Technologies Takes Over BioCheckTechne Partners with Fisher Scientific8. FOCUS ON SELECT MARKET PARTICIPANTSAbbott Laboratories (USA)Beckman Coulter, Inc. (USA)bioMérieux SA (France)Bio-Rad Laboratories Inc. (USA)DiaSorin S.p.A (Italy)Fujirebio, Inc. (Japan)Ortho-Clinical Diagnostics, Inc. (USA)Roche Diagnostics (Switzerland)Siemens Healthineers (USA)Sysmex Corporation (Japan)Quidel Corporation (USA)Tosoh Bioscience, Inc. (USA)9. GLOBAL MARKET PERSPECTIVETable 8: World Recent Past, Current & Future Analysis for Immunoassay Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 9: World Historic Review for Immunoassay Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 10: World 14-Year Perspective for Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)Immunoassay Market by TechnologyTable 11: World Recent Past, Current & Future Analysis for Enzyme Immunoassay by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 12: World Historic Review for Enzyme Immunoassay by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 13: World 14-Year Perspective for Enzyme Immunoassay by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)Table 14: World Recent Past, Current & Future Analysis for Fluorescence Immunoassay Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 15: World Historic Review for Fluorescence Immunoassay Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 16: World 14-Year Perspective for Fluorescence Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)Table 17: World Recent Past, Current & Future Analysis for Chemiluminescence Immunoassay Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 18: World Historic Review for Chemiluminescence Immunoassay Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 19: World 14-Year Perspective for Chemiluminescence Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)Table 20: World Recent Past, Current & Future Analysis for Rapid Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 21: World Historic Review for Rapid Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 22: World 14-Year Perspective for Rapid Tests by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)Table 23: World Recent Past, Current & Future Analysis for ELISPOT by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 24: World Historic Review for ELISPOT by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 25: World 14-Year Perspective for ELISPOT by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)Table 26: World Recent Past, Current & Future Analysis for Polymerase Chain Reaction (PCR) Technology by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 27: World Historic Review for Polymerase Chain Reaction (PCR) Technology by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 28: World 14-Year Perspective for Polymerase Chain Reaction (PCR) Technology by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)Table 29: World Recent Past, Current & Future Analysis for Other Immunoassays by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 30: World Historic Review for Other Immunoassays by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 31: World 14-Year Perspective for Other Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)III. MARKET1. THE UNITED STATESA.Market AnalysisCurrent and Future AnalysisIncreasing Burden of Chronic Diseases Drives Focus onto ImmunoassaysAn Overview of ELISA UsageAgeing Demographics: Major Driving FactorTable 32: North American Elderly Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)Product Launches/ApprovalsStrategic Corporate DevelopmentsFocus on Select PlayersB.Market AnalyticsTable 33: US Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 34: US Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 35: US 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)2. CANADAMarket AnalysisTable 36: Canadian Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 37: Canadian Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 38: Canadian 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)3. JAPANA.Market AnalysisOutlookProduct LaunchesFocus on Key PlayersB.Market AnalyticsTable 39: Japanese Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 40: Japanese Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 41: Japanese 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)4. EUROPEA.Market AnalysisCurrent & Future AnalysisAutomation Supports Growth in Western European IVD MarketImmunochemistry Analyzer MarketRecent Industry ActivityB.Market AnalyticsTable 42: European Recent Past, Current & Future Analysis for Immunoassay Systems by Geographic Region - France, Germany, Italy, the UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 43: European Historic Review for Immunoassay Systems by Geographic Region - France, Germany, Italy, the UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 44: European 14-Year Perspective for Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, the UK, Spain, Russia and Rest of Europe Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)Table 45: European Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 46: European Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 47: European 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)4a. FRANCEA.Market AnalysisCurrent & Future AnalysisBiomérieux - A Key PlayerB.Market AnalyticsTable 48: French Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 49: French Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 50: French 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)4b. GERMANYA.Market AnalysisCurrent & Future AnalysisProduct LaunchesB.Market AnalyticsTable 51: German Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 52: German Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 53: German 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)4c. ITALYA.Market AnalysisDiasorin S.p.A - A Key PlayerB.Market AnalyticsTable 54: Italian Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 55: Italian Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 56: Italian 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)4d. THE UNITED KINGDOMA.Market AnalysisCurrent & Future AnalysisProduct LaunchB.Market AnalyticsTable 57: UK Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 58: UK Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 59: UK 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)4e. SPAINMarket AnalysisTable 60: Spain Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 61: Spain Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 62: Spain 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)4f. RUSSIAMarket AnalysisTable 63: Russian Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 64: Russian Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 65: Russian 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)4g. REST OF EUROPEA.Market AnalysisCurrent and Future AnalysisStrategic Corporate DevelopmentsRoche Diagnostics - A Key PlayerB.Market AnalyticsTable 66: Rest of Europe Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 67: Rest of Europe Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 68: Rest of Europe 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)5. ASIA-PACIFICA.Market AnalysisCurrent and Future AnalysisGrowing In-Vitro Diagnostics (IVD) Market Fuels Demand for Immunoassay InstrumentsB.Market AnalyticsTable 69: Asia-Pacific Recent Past, Current & Future Analysis for Immunoassay Systems by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 70: Asia-Pacific Historic Review for Immunoassay Systems by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 71: Asia-Pacific 14-Year Perspective for Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for China, India and Rest of Asia-Pacific Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)Table 72: Asia-Pacific Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 73: Asia-Pacific Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 74: Asia-Pacific 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)5a. CHINAA.Market AnalysisCurrent and Future AnalysisIn-Vitro Diagnostics MarketStrategic Corporate DevelopmentB.Market AnalyticsTable 75: Chinese Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 76: Chinese Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 77: Chinese 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)5b. INDIAA.Market AnalysisCurrent and Future AnalysisImmunoassay Systems market - An OverviewEmerging TrendsB.Market AnalyticsTable 78: Indian Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 79: Indian Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 80: Indian 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)5c. REST OF ASIA-PACIFICA.Market AnalysisCurrent and Future AnalysisIndonesiaMalaysiaStrategic Corporate DevelopmentsB.Market AnalyticsTable 81: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 82: Rest of Asia-Pacific Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 83: Rest of Asia-Pacific 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)6. LATIN AMERICAMarket AnalysisTable 84: Latin American Recent Past, Current & Future Analysis for Immunoassay Systems by Geographic Region - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 85: Latin American Historic Review for Immunoassay Systems by Geographic Region - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 86: Latin American 14-Year Perspective for Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for Brazil and Rest of Latin American Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)Table 87: Latin American Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 88: Latin American Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 89: Latin American 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)6a. BRAZILMarket AnalysisTable 90: Brazilian Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 91: Brazilian Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 92: Brazilian 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)6b. REST OF LATIN AMERICAMarket AnalysisTable 93: Rest of Latin America Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 94: Rest of Latin America Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 95: Rest of Latin America 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)7. REST OF WORLDMarket AnalysisTable 96: Rest of World Recent Past, Current & Future Analysis for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 97: Rest of World Historic Review for Immunoassay Systems by Technology - Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 98: Rest of World 14-Year Perspective for Immunoassay Systems by Technology - Percentage Breakdown of Value Sales for Enzyme Immunoassay, Fluorescence Immunoassay, Chemiluminescence Immunoassay, Rapid Tests, ELISPOT, PCR, and Others Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)IV. COMPETITIVE LANDSCAPETotal Companies Profiled: 65 (including Divisions/Subsidiaries - 88) The United States (49) Canada (1) Japan (7) Europe (29) - France (3) - Germany (6) - The United Kingdom (5) - Italy (3) - Spain (1) - Rest of Europe (11) Asia-Pacific (Excluding Japan) (2)Read the full report: http://www.reportlinker.com/p04838507/Global-Immunoassay-Systems-Laboratory-Equipment-and-Supplies.htmlAbout Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.http://www.reportlinker.com
__________________________Contact Clare: [email protected]
US: (339)-368-6001Intl: +1 339-368-6001
View original content:http://www.prnewswire.com/news-releases/global-immunoassay-systems---laboratory-equipment-and-supplies-300485366.html
SOURCE Reportlinker
